Trial Condition(s):

Contraception

Effects of counseling on the continuation rates and compliance for newly prescribed oral contraceptives (Yasmin® or any other oral contraceptives (OC)

Bayer Identifier:

14565

ClinicalTrials.gov Identifier:

NCT00905684

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study is a prospective, company-sponsored, non-interventional cohort study of up to 5000 patients in European countries and countries in Middle East who are newly prescribed any available OC. Patients will be followed up approximately 6 months after initial visit. Selection of Study Population: Women can be enrolled after decision for treatment with Yasmin or any other OC has been made. Physicians should consult the full prescribing information for the respective OC before enrolling patients and familiarize themselves with the safety information in the product package label.

Inclusion Criteria
- Women who have been found eligible for OC use and have newly been prescribed an OC in accordance with the terms of the respective marketing authorization   
 - Starter (first-ever user of an OC) and switcher from another OC (incl. women with a history of OC use)
Exclusion Criteria
- The contraindications and warnings of the Summary of Product Characteristics must be followed.

Trial Summary

Enrollment Goal
8450
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, United Arab Emirates

Status
Completed
 
Locations

Investigative Site

Many locations, Albania

Status
Completed
 
Locations

Investigative Site

Many locations, Egypt

Status
Completed
 
Locations

Investigative Site

Many locations, Hungary

Status
Completed
 
Locations

Investigative Site

Many locations, Kenya

Status
Terminated
 
Locations

Investigative Site

Many locations, Macedonia

Status
Completed
 
Locations

Investigative Site

Many Locations, Saudi Arabia

Status
Completed
 
Locations

Investigative Site

Many Locations, Kuwait

Status
Completed
 
Locations

Investigative Site

Many Locations, Oman

Status
Completed
 
Locations

Investigative Site

Many Locations, Jordan

Status
Completed
 
Locations

Investigative Site

Many Locations, Lebanon

Status
Completed
 
Locations

Investigative Site

Many Locations, Bahrain

Status
Completed
 
Locations

Investigative Site

Many Locations, Qatar

Status
Completed
 

Trial Design